SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Politics for Pros- moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
bentway
To: D. Long who wrote (606148)8/26/2016 2:48:43 PM
From: DewDiligence_on_SI1 Recommendation  Read Replies (3) of 793671
 
Government regulation of a fancy needle which effectively prevents competition.
Wrong—FDA does not require a "fancy needle" to administer epinephrine; any company can apply for FDA approval to sell epinephrine with its own injection device.

What's at issue in this thread (on government conspiracies) is the FDA's rejection of Teva's application to sell a generic version of Mylan's Epipen—i.e. a product that would be automatically substitutable for Mylan's EpiPen by any pharmacist.

There is much misinformation about the FDA on this message board.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News